Publication & Citation Trends
Publications
21 total
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer PDF
Cited by 1,706
OpenAlex
Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment
Cited by 126
OpenAlex
The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.
Cited by 336
OpenAlex
Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease.
Cited by 20
OpenAlex
Correlation between c-erbB-4 receptor expression and response to gemcitabine–cisplatin chemotherapy in non-small-cell lung cancer PDF
Cited by 25
OpenAlex
CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer
Cited by 8
OpenAlex
CMF (Cyclophosphamide, Methotrexate, 5‐Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5‐Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph‐Node Positive Breast Cancer: A Phase III Randomized Multicenter Study
Cited by 8
Semantic Scholar
Research Topics
Cancer Treatment and Pharmacology
(10)
Breast Cancer Treatment Studies
(5)
Lung Cancer Treatments and Mutations
(5)
HER2/EGFR in Cancer Research
(3)
Brain Metastases and Treatment
(3)
Affiliations
Holon Institute of Technology
Tel Aviv University
Tel Aviv Sourasky Medical Center
Sheba Medical Center
Kaplan Medical Center